Document is current
Any future updates will be listed below
-
Authors
Eggebø, Maria Stadheim https://orcid.org/0009-0005-7393-2612
Heinzelbecker, Julia
Palashati, Heyilimu
Chandler, Nicholas
Tran, Trung The
Li, Yingqian
Yang, Weiwen
Laos, Maarja
Blaas, Isaac
Rustad, Even Holth
Bollineni, Ravi Chand
Delic-Sarac, Marina
Lund-Johansen, Fridtjof https://orcid.org/0000-0002-2445-1258
Nielsen, Morten Milek https://orcid.org/0000-0001-5432-2396
Olweus, Johanna https://orcid.org/0000-0002-1898-3100
- License Information
-
More Information
Article History
Received: 25 July 2024
Accepted: 15 July 2025
First Online: 27 August 2025
Competing interests
: A patent application will be filed by the Oslo University Hospital institutional technology transfer office Inven2 protecting the TCR sequences (J.O., M.M.N. and M.S.E. are inventors). J.O. is on the scientific advisory board of Asgard Therapeutics, and J.O. and F.L.-J. are cofounders of T-Rx therapeutics. The other authors declare no competing interests.
